Company: IXHL
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043682
Chunk: 19

Company: Incannex Healthcare Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 19
---
 per share.
Holders of common stock are entitled to receive any dividends as may be declared from time to time by the Company’s board of directors.

On November 28, 2023, the Company effected the
Re-domiciliation. All references in these unaudited condensed consolidated financial statements to the Company’s outstanding common
stock, including per share information, have been retrospectively adjusted to reflect this Re-domiciliation.

Note 11 – Stock-based payments

    For the nine months ended March 31, 

    2025$  
    2024$ 

    (in thousands) 
  
    Research and development 
     -  
     - 
  
    General and administrative 
     1,310  
     5,584 
  
    Total stock-based compensation expense 
     1,310  
     5,584 

    For the three months ended March 31, 

    2025$  
    2024$ 

    (in thousands) 
  
    Research and development 
     -  
     - 
  
    General and administrative 
     416  
     2,116 
  
    Total stock-based compensation expense 
     416  
     2,116 

13

Note 11 – Stock-based payments (continued) 

Restricted stock units

A summary of the changes in the Company’s
restricted stock activity for the period ended March 31, 2025, are as follows:

    Numbers of  Shares  
    Weighted  Average Grant  Date Fair Value  $ 

    (in thousands, expect per share data) 
  
    Unvested and Outstanding as of June 30, 2024 
     651,939  
     3.91 
  
    Granted 
     27,795  
     1.84 
  
    Vested 
     9,265  
     1.84 
  
    Forfeited 
     -  
     - 
  
    Unvested and Outstanding as of September 30, 2024 
     670,469  
     3.86 

    Numbers of  Shares  
    Weighted  Average Grant  Date Fair Value  $ 

    (in thousands, expect per share data) 
  
    Unvested and Outstanding as of September 30, 2024 
     670,